Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takashi Suefuji

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Molecules (Basel, Switzerland)|November 17, 2007
Addition to electron deficient olefins of alpha-oxy carbon- centered radicals, generated from cyclic ethers and acetals by the reaction with alkylperoxy- lambda(3)-iodaneTakuya Sueda, Yasunori Takeuchi, Takashi Suefuji, et al.
Organic Letters|July 1, 2005
Effects of complexation with 18-crown-6 on the hypernucleofugality of phenyl-lambda3-iodanyl groups. Synthesis of vinyl-lambda3-iodane.18-crown-6 complexMasahito Ochiai, Takashi Suefuji, Kazunori Miyamoto, et al.
Chemical Communications (Cambridge, England)|July 5, 2003
Solid state structures of pentacoordinated lambda3-iodanes with a trigonal bipyramidal geometry: synthesis of diphenyl- and alkynyl(phenyl)-lambda3-iodane complexes with 1,10-phenanthrolineMasahito Ochiai, Takashi Suefuji, Kazunori Miyamoto, et al.
Journal of the American Chemical Society|July 28, 2005
Synthesis and characterization of beta-haloalkenyl-lambda3-bromanes: stereoselective Markovnikov addition of difluoro(aryl)-lambda3-bromane to terminal acetylenesMasahito Ochiai, Yoshio Nishi, Takeshi Mori, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|March 20, 2014
Reactivity of hydroxy- and aquo(hydroxy)-λ3-iodane-crown ether complexesKazunori Miyamoto, Yukie Yokota, Takashi Suefuji, et al.
Journal of the American Chemical Society|January 16, 2003
Secondary hypervalent I(III)...O interactions: synthesis and structure of hypervalent complexes of diphenyl-lambda3-iodanes with 18-crown-6Masahito Ochiai, Takashi Suefuji, Kazunori Miyamoto, et al.
Molecular Cancer Therapeutics|October 22, 2013
The novel VEGF receptor/MET-targeted kinase inhibitor TAS-115 has marked in vivo antitumor properties and a favorable tolerability profileHidenori Fujita, Kazutaka Miyadera, Masanori Kato, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Molecules (Basel, Switzerland)|November 17, 2007
Addition to electron deficient olefins of alpha-oxy carbon- centered radicals, generated from cyclic ethers and acetals by the reaction with alkylperoxy- lambda(3)-iodaneTakuya Sueda, Yasunori Takeuchi, Takashi Suefuji, et al.
Organic Letters|July 1, 2005
Effects of complexation with 18-crown-6 on the hypernucleofugality of phenyl-lambda3-iodanyl groups. Synthesis of vinyl-lambda3-iodane.18-crown-6 complexMasahito Ochiai, Takashi Suefuji, Kazunori Miyamoto, et al.
Chemical Communications (Cambridge, England)|July 5, 2003
Solid state structures of pentacoordinated lambda3-iodanes with a trigonal bipyramidal geometry: synthesis of diphenyl- and alkynyl(phenyl)-lambda3-iodane complexes with 1,10-phenanthrolineMasahito Ochiai, Takashi Suefuji, Kazunori Miyamoto, et al.
Journal of the American Chemical Society|July 28, 2005
Synthesis and characterization of beta-haloalkenyl-lambda3-bromanes: stereoselective Markovnikov addition of difluoro(aryl)-lambda3-bromane to terminal acetylenesMasahito Ochiai, Yoshio Nishi, Takeshi Mori, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|March 20, 2014
Reactivity of hydroxy- and aquo(hydroxy)-λ3-iodane-crown ether complexesKazunori Miyamoto, Yukie Yokota, Takashi Suefuji, et al.
Journal of the American Chemical Society|January 16, 2003
Secondary hypervalent I(III)...O interactions: synthesis and structure of hypervalent complexes of diphenyl-lambda3-iodanes with 18-crown-6Masahito Ochiai, Takashi Suefuji, Kazunori Miyamoto, et al.
Molecular Cancer Therapeutics|October 22, 2013
The novel VEGF receptor/MET-targeted kinase inhibitor TAS-115 has marked in vivo antitumor properties and a favorable tolerability profileHidenori Fujita, Kazutaka Miyadera, Masanori Kato, et al.
Pageof 1